84 related articles for article (PubMed ID: 21391426)
21. Direct revascularization is superior for rat parathyroid allotransplantation with FK506.
Nelson M; Dan O; Strome M
Ann Otol Rhinol Laryngol; 2005 Mar; 114(3):207-13. PubMed ID: 15825570
[TBL] [Abstract][Full Text] [Related]
22. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
[TBL] [Abstract][Full Text] [Related]
23. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
[TBL] [Abstract][Full Text] [Related]
24. Once daily everolimus is safe and effective in de novo renal transplant recipients: six-month results of a pilot study.
Favi E; Spagnoletti G; Gargiulo A; Salerno MP; Romagnoli J; Citterio F
Transplant Proc; 2010 May; 42(4):1308-11. PubMed ID: 20534287
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
[TBL] [Abstract][Full Text] [Related]
27. Effects of adding steroids, in vitro irradiation, or both to cyclosporine immunosuppression in the murine laryngeal transplantation model.
Lorenz RR; Dan O; Haug M; Strome M
Ann Otol Rhinol Laryngol; 2002 May; 111(5 Pt 1):455-9. PubMed ID: 12019516
[TBL] [Abstract][Full Text] [Related]
28. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
Lott DG; Dan O; Lu L; Strome M
Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
[TBL] [Abstract][Full Text] [Related]
29. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS
Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307
[TBL] [Abstract][Full Text] [Related]
31. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus.
von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335
[TBL] [Abstract][Full Text] [Related]
32. Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX.
von Suesskind-Schwendi M; Valenti V; Haneya A; Pühler T; Bewig B; Schmid C; Hirt SW; Lehle K
Histol Histopathol; 2013 Oct; 28(10):1273-84. PubMed ID: 23471704
[TBL] [Abstract][Full Text] [Related]
33. Effect of immunosuppression on survival of allograft limbal stem cells.
Chen W; Cao L; Hara K; Yoshitomi T
Jpn J Ophthalmol; 2004; 48(5):440-7. PubMed ID: 15486765
[TBL] [Abstract][Full Text] [Related]
34. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
35. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival.
Heidecke CD; Hancock WW; Jakobs F; Westerholt S; Sewzcik T; Deusch K; Zantl N; Kurrle R; Kupiec-Weglinski J
Transplant Proc; 1993 Feb; 25(1 Pt 1):540-2. PubMed ID: 8438405
[No Abstract] [Full Text] [Related]
36. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.
Gomez-Camarero J; Salcedo M; Rincon D; Lo Iacono O; Ripoll C; Hernando A; Sanz C; Clemente G; Bañares R
Transplantation; 2007 Sep; 84(6):786-91. PubMed ID: 17893613
[TBL] [Abstract][Full Text] [Related]
37. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
38. Short-term immunosuppression after rat parathyroid allotransplantation.
Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
[TBL] [Abstract][Full Text] [Related]
39. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat alpha/beta-T cell receptor monoclonal antibody.
Knight RJ; Kurrle R; Stepkowski S; Serino F; Chou TC; Kahan BD
Transplantation; 1994 Jun; 57(11):1544-8. PubMed ID: 8009587
[TBL] [Abstract][Full Text] [Related]
40. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]